These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 813612)

  • 21. Study of Pseudomonas aeruginosa in relation to pyocine typing drug sensitivity and epidemiology.
    Mohanty SK; Bhuyan BK; Nathsarma KC; Nanda BK
    Indian J Pathol Microbiol; 1982 Jan; 25(1):45-9. PubMed ID: 6809612
    [No Abstract]   [Full Text] [Related]  

  • 22. Possibility of using purified pyocins for typing Pseudomonas aeruginosa: purification of pyocins and sensitivity of P. aeruginosa in different tests.
    Jurado Chacon D; Chueca Sancho A; Guillen Solvas JF; Garcia-Villanova Ruiz B; Galvez Vargas R
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(3):253-66. PubMed ID: 3122639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plant-expressed pyocins for control of Pseudomonas aeruginosa.
    Paškevičius Š; Starkevič U; Misiūnas A; Vitkauskienė A; Gleba Y; Ražanskienė A
    PLoS One; 2017; 12(10):e0185782. PubMed ID: 28973027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pyocin R1 on the glucose metabolism of sensitive cells of Pseudomonas aeruginosa.
    Kageyama M
    J Biochem; 1978 Dec; 84(6):1373-9. PubMed ID: 104980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the biosynthesis and morphogenesis of R-type pyocins of Pseudomonas aeruginosa. IV. Quantitative estimation of the rates of synthesis of pyocin R subunit proteins.
    Shinomiya T
    J Biochem; 1974 Nov; 76(5):1083-94. PubMed ID: 4217793
    [No Abstract]   [Full Text] [Related]  

  • 26. [Inhibition of the growth of bacterial populations by suspensions obtained from Pseudomonas aeruginosa pyocinogenic strains].
    García-Quintana HG; Flores ME
    Can J Microbiol; 1983 May; 29(5):471-5. PubMed ID: 6411312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pyocin types and proteolytic properties of Pseudomonas pyocyanea organisms in burned patients and in the milieu of the Division of Burns, Institute of Hematology in Warsaw].
    Bukowska D; Serafińska D; Nasilowski W; Zietkiewicz W
    Pol Tyg Lek; 1976 Jun; 31(26):1107-10. PubMed ID: 821048
    [No Abstract]   [Full Text] [Related]  

  • 29. A fluorescent probe response to the interaction of pyocin R1 with sensitive cells.
    Uratani Y; Kageyama M
    J Biochem; 1977 Feb; 81(2):333-41. PubMed ID: 403184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of pyocins from Pseudomonas aeruginosa.
    Al-Shibib A; Al-Mudhaffar S; Al-Ani F; Hassan F
    Folia Microbiol (Praha); 1985; 30(1):25-9. PubMed ID: 3920127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope.
    Uratani Y
    J Bacteriol; 1982 Feb; 149(2):523-8. PubMed ID: 6799489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of pyocins R from Pseudomonas aeruginosa.
    al-Rubiee R; al-Mudaffar S; Hassan F; al-Ani F
    Folia Microbiol (Praha); 1988; 33(6):520-4. PubMed ID: 3149253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between aminosugars in the lipopolysaccharide, serotype, and aeruginocin sensitivity in strains of Pseudomonas aeruginosa.
    Koval SF; Meadow PM
    J Gen Microbiol; 1975 Dec; 91(2):437-40. PubMed ID: 812944
    [No Abstract]   [Full Text] [Related]  

  • 34. Mode of action of pyocin R1.
    Iijima M
    J Biochem; 1978 Feb; 83(2):395-402. PubMed ID: 416014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between aminosurgars in the lipopolysaccharide, serotype, and aeruginocin sensitivity in strains of Pseudomonas aeruginosa.
    Koval SF; Meadow PM
    J Gen Microbiol; 1975 Dec; 91(2):437-40. PubMed ID: 812945
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyocin sensitivity of Neisseria gonorrhoeae and its feasibility as an epidemiological tool.
    Sidberry HD; Sadoff JC
    Infect Immun; 1977 Feb; 15(2):628-37. PubMed ID: 403141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and characterization of pyocin-colicin chimeric proteins.
    Kageyama M; Kobayashi M; Sano Y; Masaki H
    J Bacteriol; 1996 Jan; 178(1):103-10. PubMed ID: 8550402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa.
    Sano Y; Matsui H; Kobayashi M; Kageyama M
    J Bacteriol; 1993 May; 175(10):2907-16. PubMed ID: 8491711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification of the pyocin S2 complex from Pseudomonas aeruginosa PAO1: analysis of DNase activity.
    Seo Y; Galloway DR
    Biochem Biophys Res Commun; 1990 Oct; 172(2):455-61. PubMed ID: 2122894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of active transport and macromolecular synthesis by pyocin 103 in Neisseria gonorrhoeae.
    Stein DC; Clark VL; Young FE
    Sex Transm Dis; 1983; 10(1):7-13. PubMed ID: 6189200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.